Halodine Engages Emery Pharma for Next Generation Development of Oral and Nasal Antiseptics Active Against SARS-CoV-2 (COVID-19), July 30, 2020.

Halodine VP Medical Affairs & Global Outreach, Samuel Kojo Amoakohene MD, a 2020 National Xconomy Awards Finalist for Social Responsibility, the Only Individual to Achieve the Honor.

Montco spinout to accelerate production of Covid-19 nasal antiseptic and mouth rinse, J. George, Philadelphia Business Journal, July 20, 2020.

Biopharmaceutical Company Which Has Developed First Nasal and Oral Antiseptics for COVID-19 has Origins at New York Eye and Ear Infirmary, Mount Sinai Alumni News, June 2020.

UConn Health Researchers Find a Simple Oral Rinse Can Inactivate the COVID-19 Virus, C. Chandler, UConn Today, June 18, 2020.

Povidone‐Iodine Oral Antiseptic Rinse and Inactivation of SARS‐CoV‐2, Journal of Prosthodontics News, June 15, 2020.

Halodine Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19), May 13, 2020.